U.S. flag

An official website of the United States government

NM_004360.5(CDH1):c.1711+1dup AND Hereditary diffuse gastric adenocarcinoma

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Jun 14, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001384616.9

Allele description [Variation Report for NM_004360.5(CDH1):c.1711+1dup]

NM_004360.5(CDH1):c.1711+1dup

Gene:
CDH1:cadherin 1 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
16q22.1
Genomic location:
Preferred name:
NM_004360.5(CDH1):c.1711+1dup
HGVS:
  • NC_000016.10:g.68819426dup
  • NG_008021.1:g.87135dup
  • NM_001317184.2:c.1528+1dup
  • NM_001317185.2:c.163+1dup
  • NM_001317186.2:c.-254-2575dup
  • NM_004360.5:c.1711+1dupMANE SELECT
  • LRG_301:g.87135dup
  • NC_000016.9:g.68853327_68853328insG
  • NC_000016.9:g.68853329dup
Note:
ClinGen staff contributed the HGVS expression for this variant.
Nucleotide change:
1-BP INS, 1711G
Links:
OMIM: 192090.0013; dbSNP: rs2152137028
NCBI 1000 Genomes Browser:
rs2152137028
Molecular consequence:
  • NM_001317186.2:c.-254-2575dup - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001317184.2:c.1528+1dup - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001317185.2:c.163+1dup - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_004360.5:c.1711+1dup - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Hereditary diffuse gastric adenocarcinoma (HDGC)
Synonyms:
Hereditary diffuse gastric cancer
Identifiers:
MONDO: MONDO:0007648; MedGen: C1708349; Orphanet: 26106; OMIM: 137215

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001584183Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 31, 2020)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV004043652Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))
Likely pathogenic
(Jun 14, 2023)
unknownclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.

Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S, et al.

J Med Genet. 2004 Jul;41(7):508-17.

PubMed [citation]
PMID:
15235021
PMCID:
PMC1735838

Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Guilford P, Humar B, Blair V.

Gastric Cancer. 2010 Mar;13(1):1-10. doi: 10.1007/s10120-009-0531-x. Epub 2010 Apr 7. Review.

PubMed [citation]
PMID:
20373070
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV001584183.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CDH1 are known to be pathogenic (PMID: 15235021, 20373070). This variant has been observed in individual(s) with diffuse gastric cancer (PMID: 9751616, 11419427). It has also been observed to segregate with disease in related individuals. This variant is also known as 1711insG in the literature. ClinVar contains an entry for this variant (Variation ID: 12242). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser572Phefs*16) in the CDH1 gene. It is expected to result in an absent or disrupted protein product.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Myriad Genetics, Inc., SCV004043652.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 7, 2024